Patent Assignment
Reel/Frame 066089/0235
Security Interest
Recorded: 2023-12-21
Pages: 27
Assignor
BIORA THERAPEUTICS, INC.
Executed: 2023-12-19
Assignee
GLAS TRUST COMPANY LLC, AS COLLATERAL AGENT
3 SECOND STREET, SUITE 206, ATTENTION: TMGUS/BIORA THERAPEUTICS, INC., JERSEY CITY, NEW JERSEY, 07311
Covered Properties
(189)
Aqueous Formulations of Tofactinib and Tofacitinib Salts
PCT:
PCT/US2022/043136 ↗
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
PCT:
PCT/US2023/064716 ↗
Electronically and Remotely Controlled Pill and System for Delivering at Least One Medicament
Electronic Gastrointestinal Screening
Device for Controlled Release of Chemical Molecules
Device for Drug Administration and/or Monitoring the Status of a Patient
Electronic Capsule for Treating Gastrointestinal Disease
Medicament Delivery System and Process
Medicament Delivery Apparatus
Miniaturized Threshold Sensor
Design of Swallowable Multi-Nozzle Dosing Device for Releasing Medicines in the Gastrointestinal Tract
Medicament Delivery Device, Capsule and in Vivo Medicine Delivery or Diagnostic System
Ingestible Electronic Capsule and in Vivo Drug Delivery or Diagnostic System
Method of Preparing a Swallowable Capsule Comprising a Sensor
Device for Delivery of Powder Like Medication in a Humid Environment
Electronic Pill Comprising a Plurality of Medicine Reservoirs
Electronic Pill Comprising a Medicine Reservoir
Modular Ingestible Drug Delivery Capsule
Medicine Reservoir for Drug Delivery Device
Drug Delivery Device with Compressible Drug Reservoir
Electronic Pill for Delivery of Powder Medication
Swallowable Medication Capsule
Electronically And Remotely Controlled Pill And System For Delivering At Least One Medicament
Drug Delivery Capsules With External Intelligence
Ingestible Medical Device
Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
Active Agent Delivery Devices and Methods of Using the Same
Electromechanical Pill Device with Localization Capabilities
Sampling Systems and Related Materials and Methods
Gastrointestinal Tract Detection Methods, Devices and Systems
Ingestible Device and Associated Methods
Localization Systems and Methods for an Ingestible Device
Ingestible Medical Device
Application:
16/194,563 →
Publication:
US 2019/0083073
Ingestible Device With Relatively Large Payload Volume
Ingestible Device with on-Board Fluorometer and Related Systems and Methods
Application:
16/434,118 →
Publication:
US 2019/0374207
Ingestible Device Recovery System
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
16/465,360 →
Publication:
US 2019/0343425
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor Released Using an Ingestible Device
Treatment of a Disease of the Gastrointestinal Tract with a Chemokine/Chemokine Receptor Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
16/467,744 →
Publication:
US 2020/0253506
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Modulator
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent Released Using an Ingestible Device
Application:
16/496,791 →
Publication:
US 2021/0138213
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Treatment of a Disease of the Gastrointestinal Tract with Glatiramer or a Pharmaceutically Acceptable Salt Thereof
Application:
16/639,060 →
Publication:
US 2020/0306516
Treatment of a Disease of the Gastrointestinal Tract with a S1P Modulator
Application:
16/769,983 →
Publication:
US 2022/0135666
Sampling Systems and Related Materials and Methods
Application:
16/787,557 →
Publication:
US 2020/0170627
Gastrointestinal Tract Detection Methods, Devices and Systems
Ingestible Device for Delivery of a Dispensable Substance
Active Agent Delivery Devices and Methods of Using the Same
Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Electromechanical Pill Device with Localization Capabilities
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application:
17/059,058 →
Publication:
US 2021/0386367
Assessment of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Delivery Capsule with Threshold Release
Application:
17/170,381 →
Publication:
US 2021/0161805
Treatment of a Disease of the Gastrointestinal Tract with a Chemokine/Chemokine Receptor Inhibitor
Application:
17/194,587 →
Publication:
US 2022/0071894
Methods for Collecting and Testing Bacteria Containing Samples from Within the Gastrointestinal Tract
Preeclampsia Biomarkers and Related Systems and Methods
Treatment of a Disease of the Gastrointestinal Tract with an Immunomodulator
Application:
17/253,799 →
Publication:
US 2023/0041197
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
17/253,802 →
Publication:
US 2021/0363233
Method of Formulating a Pharmaceutical Composition Comprising Administering an Immune Modulator to the Intestine
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
17/253,806 →
Publication:
US 2023/0033021
Treatment of a Disease of the Gastrointestinal Tract with a Jak or Other Kinase Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
17/253,811 →
Publication:
US 2023/0312700
Methods and Devices for Treating a Disease with Biotherapeutics
Application:
17/295,275 →
Publication:
US 2023/0023414
Methods and Devices for Treating a Disease with Biotherapeutics
Application:
17/295,277 →
Publication:
US 2022/0249814
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
17/295,282 →
Publication:
US 2024/0252795
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Assessment of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Preeclampsia Biomarkers and Related Systems and Methods
Application:
17/691,399 →
Publication:
US 2022/0268781
Assessment of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Application:
17/710,756 →
Publication:
US 2023/0052697
Ingestible Device and Associated Methods
Application:
17/745,549 →
Publication:
US 2022/0273196
Localization Systems and Methods for an Ingestible Device
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Modulator
Application:
17/864,319 →
Publication:
US 2023/0019619
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor Released Using an Ingestible Device
Application:
18/174,603 →
Publication:
US 2025/0230229
Methods of Treating and Predicting Non-Response to Anti-Tnf Treatment in Subjects with Gastrointestinal Tract Diseases
Application:
18/250,202 →
Publication:
US 2025/0325662
Electromechanical Ingestible Device for Delivery of a Dispensable Substance
Application:
18/360,744 →
Publication:
US 2023/0363663
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Application:
18/384,378 →
Publication:
US 2024/0252425
Active Agent Delivery Devices and Methods of Using the same
Application:
18/525,612 →
Publication:
US 2024/0108869
Ingestible Medical Device
Application:
61/600,029 →
Electromechanical Pill Device with Localization Capabilities
Application:
62/055,244 →
Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
Application:
62/198,654 →
Systems and Methods for Obtaining Samples Using Ingestible Devices
Application:
62/376,688 →
Electromechanical Ingestible Device for Delivery of a Dispensable Substance
Application:
62/385,553 →
Compositions, Methods, and Devices for Bacteria Detection and Quantitation
Application:
62/431,297 →
Ingestible Device Recovery System
Application:
62/434,188 →
Ingestible Device for Sampling, Diluting and Culturing a Biological Sample
Application:
62/434,320 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/434,348 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/434,363 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application:
62/434,366 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/434,369 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application:
62/434,371 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/434,372 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/434,374 →
Ingestible Device and Associated Methods
Application:
62/434,797 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/478,744 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application:
62/478,840 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application:
62/478,846 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/478,863 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/478,919 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/478,937 →
Electromechanical Ingestible Device for Delivery of a Dispensable Substance
Application:
62/478,955 →
Treatment of a Disease of the Gastrointestinal Tract with Stem Cells
Application:
62/479,027 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/479,118 →
Localization Systems and Methods for an Optoelectromechanical Pill Device
Application:
62/480,187 →
Devices for Analyte Detection
Application:
62/502,383 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application:
62/507,008 →
Localization Systems and Methods for an Ingestible Device
Application:
62/540,873 →
Treatment of a Disease of the Gastrointestinal Tract with a CD40/CD40L Inhibitor
Application:
62/545,129 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/545,157 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/545,188 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application:
62/545,219 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/545,220 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application:
62/545,232 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/545,240 →
Treatment of a Disease of the Gastrointestinal Tract with Live Biotherapeutics
Application:
62/545,297 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application:
62/545,311 →
Treatment of a Disease of the Gastrointestinal Tract with Glatiramer Acetate
Application:
62/545,330 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/545,380 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/545,894 →
Preeclampsia Markers
Application:
62/558,184 →
Ingestible Devices and Related Systems and Methods
Application:
62/560,618 →
Ingestible Device and Associated Methods
Application:
62/570,411 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/583,768 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/583,797 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application:
62/583,800 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/583,804 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application:
62/583,806 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application:
62/583,823 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/583,832 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/583,861 →
Treatment of a Disease of the Gastrointestinal Tract with Glatiramer Acetate
Application:
62/583,898 →
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent
Application:
62/583,921 →
Treatment of a Disease of the Gastrointestinal Tract with a Chemokine/Chemokine Receptor Inhibitor
Application:
62/583,929 →
Treatment of a Disease of the Gastrointestinal Tract with Live Biotherapeutics
Application:
62/583,932 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/583,969 →
Treatment of a Disease of the Gastrointestinal Tract with Live Biotherapeutics
Application:
62/596,040 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/596,041 →
Treatment of a Disease of the Gastrointestinal Tract with Live Biotherapeutics
Application:
62/598,948 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application:
62/598,957 →
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent
Application:
62/598,966 →
Treatment of a Disease of the Gastrointestinal Tract with Glatiramer Acetate
Application:
62/598,972 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/599,000 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/599,005 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application:
62/622,639 →
Ingestible Device with Relatively Large Payload Volume
Application:
62/642,544 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application:
62/650,850 →
Treatment of a Disease of the Gastrointestinal Tract with Glatiramer Acetate
Application:
62/650,883 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/650,900 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application:
62/679,659 →
Ingestible Device with on-Board Fluorometer and Related Systems and Methods
Application:
62/681,589 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/687,429 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/687,546 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application:
62/687,683 →
Treatment of a Disease of the Gastrointestinal Tract with a S1P Modulator
Application:
62/687,697 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/687,745 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/687,751 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/687,756 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/687,766 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application:
62/751,209 →
Ingestible Device With High Pressure Substance Delivery to the Gastrointestinal Tract
Application:
62/769,496 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/786,275 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/804,385 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/804,828 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/804,840 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/805,099 →
Ingestible Device With High Pressure Substance Delivery to the Gastrointestinal Tract
Application:
62/818,731 →
Ingestible Device With High Pressure Substance Delivery to the Gastrointestinal Tract
Application:
62/819,513 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application:
62/829,225 →
Ingestible Device and Method of Use to Deliver Therapeutic Agent to the Gastrointestinal Tract
Application:
62/932,459 →
Detection of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Application:
62/943,739 →
Detection of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Application:
62/947,957 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
62/948,082 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
63/027,427 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
63/086,630 →
Methods of Treating and Predicting Non-response to Anti-TNF Treatment in Subjects with a Disease of the Gastrointestinal Tract
Application:
63/104,399 →
Methods of Treating and Predicting Non-Response to Anti-Tnf Treatment in Subjects with a Disease of the Gastrointestinal Tract
Application:
63/182,678 →
Aqueous Formulations of Tofacitinib and Tofacitinib Salts
Application:
63/242,436 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Track
Application:
63/321,537 →
Trigger Assembly for Ingestible Drug Delivery Device
Application:
63/580,213 →
Ingestible Drug Delivery Device
Application:
63/584,466 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 23, 2007
From: TROVATO, KAREN I.; SPEKOWIUS, GERHARD
To: KONINKLIJKE PHILIPS ELECTRONICS N.V.
Reel/Frame 018928/0167 →
Assignment of Assignor's Interest
Jun 6, 2008
From: SHIMIZU, JEFF; TROVATO, KAREN
To: KONINKLIJKE PHILIPS ELECTRONICS, N.V.
Reel/Frame 021056/0209 →
Assignment of Assignor's Interest
Jun 19, 2008
From: KRIJNSEN, HENDRIKA CECILIA; LANGEREIS, GEERT; VAN BRUGGEN, MICHEL PAUL BARBARA; IORDANOV, VENTZESLAV PETROV
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 021116/0856 →
Assignment of Assignor's Interest
Nov 7, 2008
From: KRIJNSEN, HENRIKE; LANGEREIS, GEERT; VAN BRUGGEN, MICHEL; IORDANOV, VENTZESLAV
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 021800/0832 →
Assignment of Assignor's Interest
Dec 16, 2008
From: SHIMIZU, JEFF; TROVATO, KAREN I.
To: KONINKLIJKE PHILIPS ELECTRONICS, N.V.
Reel/Frame 021988/0126 →
Assignment of Assignor's Interest
Dec 22, 2008
From: TROVATO, KAREN I.; SHIMIZU, JEFF
To: KONINKLIJKE PHILIPS ELECTRONICS N.V.
Reel/Frame 022014/0113 →
Assignment of Assignor's Interest
Mar 26, 2009
From: SHIMIZU, JEFF; ZOU, HANS; DIJKSMAN, JOHAN FREDERIK; PIERIK, ANKE
To: KONINKLIJKE PHILIPS ELECTRONICS N. V.
Reel/Frame 022452/0761 →
Assignment of Assignor's Interest
Apr 29, 2009
From: DIJKSMAN, JOHAN FREDERIK; PIERIK, ANKE; RENSEN, JUDITH MARGREET; SHIMIZU, JEFF
To: KONINKLIJKE PHILIPS ELECTRONICS N.V.
Reel/Frame 022615/0107 →
Assignment of Assignor's Interest
May 18, 2009
From: DIJKSMAN, JOHAN FREDERIK; DE JONGH, FRITS TOBI; PARDOEL, MICHEL GERARDUS; PIERIK, ANKE
To: KONINKLIJKE PHILIPS ELECTRONICS N.V.
Reel/Frame 022698/0545 →
Assignment of Assignor's Interest
May 19, 2009
From: DIJKSMAN, JOHAN FREDERIK; DE JONGH, FRITS TOBI; PARDOEL, MICHAEL GERARDUS; MALAURIE, CLAUDE JEAN-MARIE
To: KONINKLIJKE PHILIPS ELECTRONICS N.V.
Reel/Frame 022700/0733 →
Assignment of Assignor's Interest
Nov 3, 2009
From: DIJKSMAN, JOHAN FREDERIK; PIERIK, ANKE; RENSEN, JUDITH MARGREET; SHIMIZU, JEFF
To: KONINKLIJKE PHILIPS ELECTRONICS N.V.
Reel/Frame 023462/0431 →
Assignment of Assignor's Interest
Sep 23, 2010
From: DIJKSMAN, JOHAN FREDERIK; PIERIK, ANKE; RENSEN, JUDITH MARGREET; SHIMIZU, JEFF
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 025032/0022 →
Assignment of Assignor's Interest
Nov 12, 2010
From: ZOU, HANS; SHIMIZU, JEFF; ALBU, LUCIAN REMUS; DIJKSMAN, JOHAN FREDERIK
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 025357/0628 →
Assignment of Assignor's Interest
Jan 6, 2011
From: DIJKSMAN, JOHAN FREDERIK; PIERIK, ANKE; SHIMIZU, JEFF; ZOU, HANS
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 025591/0445 →
Assignment of Assignor's Interest
Jan 11, 2011
From: ZOU, HANS; SHIMIZU, JEFF; ALBU, LUCIAN R.; DIJKSMAN, JOHAN F.
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 025615/0532 →
Assignment of Assignor's Interest
Jan 16, 2012
From: DIJKSMAN, JOHAN FREDERIK; PIERIK, ANKE; DE JONGH, FRITS TOBI; SHIMIZU, JEFF
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 027537/0402 →
Assignment of Assignor's Interest
Feb 24, 2012
From: KONINKLIJKE PHILIPS ELECTRONICS N.V.
To: MEDIMETRICS PERSONALIZED DRUG DELIVERY B.V.
Reel/Frame 027756/0865 →
Assignment of Assignor's Interest
Aug 31, 2017
From: MEDIMETRICS PERSONALIZED DRUG DELIVERY B.V.
To: STOCO 10 GMBH
Reel/Frame 043463/0820 →
Assignment of Assignor's Interest
May 17, 2018
From: STOCO 10 GMBH
To: PROGENITY, INC.
Reel/Frame 045831/0981 →
Change of Name
Jun 14, 2023
From: PROGENITY, INC.
To: BIORA THERAPEUTICS, INC.
Reel/Frame 063991/0731 →
Change of Name
Sep 19, 2023
From: PROGENITY, INC.
To: BIORA THERAPEUTICS, INC.
Reel/Frame 064961/0451 →
Assignment of Assignor's Interest
Jul 30, 2024
From: QUINTANA, NELSON; SHIMIZU, JEFFREY A.; WAHL, CHRISTOPHER LOREN; SINGH, SHARAT
To: BIORA THERAPEUTICS, INC.
Reel/Frame 068124/0900 →
Assignment of Assignor's Interest
Jul 30, 2024
From: TEAM CONSULTING LIMITED
To: BIORA THERAPEUTICS, INC.
Reel/Frame 068124/0283 →
Assignment of Assignor's Interest
Jul 30, 2024
From: ABERCROMBIE, STUART ROBERT; MUDGE, EDWARD; SALT, NICHOLAS MARK; STEVENS, NIA ELERI
To: TEAM CONSULTING LIMITED
Reel/Frame 068124/0071 →
Assignment of Assignor's Interest
Jul 30, 2024
From: ALTAVIZ, LLC
To: BIORA THERAPEUTICS, INC.
Reel/Frame 068124/0007 →